bioRxivCancer Biology
Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes
M. Bustoros, S. Anand, R. Sklavenitis-Pistofidis, R. Redd, E. M. Boyle, B. Zhitomirsky, A. J. Dunford, Y.-T. Tai, S. J. Chavda, C. Boehner, C. J. Neuse, M. Rahmat, A. Dutta, T. Casneuf, R. Verona, E. Kastritis, L. Trippa, C. Stewart, B. A. Walker, F. E. Davies, M.-A. Dimopoulos, L. Bergsagel, K. Yong, G. J. Morgan, F. Aguet, , I. M. Ghobrial
Abstract
Smoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with significant heterogeneity in disease progression. Existing clinical models of progression risk do not fully capture this heterogeneity. Here we integrated 42 genetic alterations from 214 SMM patients using unsupervised binary matrix factorization (BMF) clustering and identified six distinct genetic subtypes. These subtypes were differentially associated with established MM-related RNA signatures, oncogenic and immune transcriptional profiles, and evolving clinical biomarkers. Three subtypes were associated with increased risk of progression to active MM in both the primary and validation cohorts, indicating they can be used to better predict high and low-risk patients within the currently used clinical risk stratification model.
- organism: human
- assay: bulk RNA-seq
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patient Similarity Network of Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic and Clinical Features
S. Bhalla, D. T. Melnekoff, … S. Parekh·bioRxiv·Jun 2, 2020
- Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study
Sheri Skerget, Daniel Peñaherrera, … Jonathan J. Keats·medRxiv·Aug 2, 2021
- Integrative multi-omics identifies high risk Multiple Myeloma segment associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways
M. Ortiz Estevez, M. Samur, … A. Thakurta·bioRxiv·Sep 3, 2021
- Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies
F. Bayer, M. Roncador, … J. Kuipers·bioRxiv·Oct 25, 2023
- Genetic program activity delineates risk, relapse, and therapy responsiveness in Multiple Myeloma
Matthew A. Wall, Serdar Turkarslan, … Nitin S. Baliga·npj Precision OncologyPeer-reviewed·Jun 28, 2021
- Preclinical models of human multiple myeloma subgroups
W. Winkler, C. Farre Diaz, … M. Janz·bioRxiv·Aug 28, 2021